» Articles » PMID: 10477564

Involvement of the SHP-1 Tyrosine Phosphatase in Regulation of T Cell Selection

Overview
Journal J Immunol
Date 1999 Sep 8
PMID 10477564
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The selection events shaping T cell development in the thymus represent the outcome of TCR-driven intracellular signaling cascades evoked by Ag receptor interaction with cognate ligand. In view of data indicating TCR-evoked thymocyte proliferation to be negatively modulated by the SHP-1 tyrosine phosphatase, a potential role for SHP-1 in regulating selection processes was investigated by analysis of T cell development in H-Y TCR transgenic mice rendered SHP-1 deficient by introduction of the viable motheaten mutation or a dominant negative SHP-1-encoding transgene. Characterization of thymocyte and peripheral T cell populations in H-Y TCR-viable motheaten mice revealed TCR-evoked proliferation as well as the positive and negative selection of H-Y-specific thymocytes to be enhanced in these mice, thus implicating SHP-1 in the negative regulation of each of these processes. T cell selection processes were also augmented in H-Y TCR mice carrying a transgene driving lymphoid-restricted expression of a catalytically inert, dominant-negative form of SHP-1. SHP-1-negative effects on thymocyte TCR signaling were not influenced by co-cross-linking of the CD28 costimulatory and/or CTLA-4 inhibitory receptors and appear, accordingly, to be realized independently of these comodulators. These observations indicate that SHP-1 raises the signaling threshold required for both positive and negative selection and reveal the inhibitory effects of SHP-1 on TCR signaling to be cell autonomous. The demonstrated capacity for SHP-1 to inhibit TCR-evoked proliferation and selection indicate SHP-1 modulatory effects on the magnitude of TCR-generated signal to be a key factor in determining the cellular consequences of TCR-ligand interaction.

Citing Articles

Treg-specific deletion of the phosphatase SHP-1 impairs control of inflammation .

Gu Q, Tung K, Lorenz U Front Immunol. 2023; 14:1139326.

PMID: 37006301 PMC: 10060847. DOI: 10.3389/fimmu.2023.1139326.


Concomitant deletion of Ptpn6 and Ptpn11 in T cells fails to improve anticancer responses.

Ventura P, Gakovic M, Fischer B, Spinelli L, Rota G, Pathak S EMBO Rep. 2022; 23(11):e55399.

PMID: 36194675 PMC: 9638855. DOI: 10.15252/embr.202255399.


Protein Tyrosine Phosphatases: Regulators of CD4 T Cells in Inflammatory Bowel Disease.

Pike K, Tremblay M Front Immunol. 2018; 9:2504.

PMID: 30429852 PMC: 6220082. DOI: 10.3389/fimmu.2018.02504.


Deletion in CD4 Cells Does Not Affect T Cell Development and Functions but Causes Cartilage Tumors in a T Cell-Independent Manner.

Miah S, Jayasuriya C, Salter A, Reilly E, Fugere C, Yang W Front Immunol. 2017; 8:1326.

PMID: 29085371 PMC: 5650614. DOI: 10.3389/fimmu.2017.01326.


T Cells Deficient in the Tyrosine Phosphatase SHP-1 Resist Suppression by Regulatory T Cells.

Mercadante E, Lorenz U J Immunol. 2017; 199(1):129-137.

PMID: 28550200 PMC: 5510748. DOI: 10.4049/jimmunol.1602171.